Shopping Cart
- Remove All
- Your shopping cart is currently empty
EBOV-IN-5 (compound 14) serves as an antiviral agent targeting the Ebola virus (EBOV) by disrupting its entry mechanism into host cells. It specifically blocks the interaction between the EBOV glycoprotein EBOV-GPcl and the essential host receptor NPC1, which is crucial for the virus's fusion and entry into the cell. [7] [1]
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | EBOV-IN-5 (compound 14) serves as an antiviral agent targeting the Ebola virus (EBOV) by disrupting its entry mechanism into host cells. It specifically blocks the interaction between the EBOV glycoprotein EBOV-GPcl and the essential host receptor NPC1, which is crucial for the virus's fusion and entry into the cell. [7] [1] |
In vitro | EBOV-IN-5 (compound 14) has a CC50 of 30 μM in HeLa cells and exhibits low cytotoxicity in Vero cells, with a CC50 of over 100 μM [1]. At a concentration of 50 μM, EBOV-IN-5 significantly disrupts the EBOV-GPcl/NPC1 interaction, with an IC50 of 4.69 μM against EBOV-GP-pseudotyped virus (pEBOV) [1]. Additionally, EBOV-IN-5 has an IC50 of 35.17 μM against the African swine fever virus (ASFV) [1]. |
Molecular Weight | 408.9 |
Formula | C18H21ClN4O3S |
Cas No. | 68207-15-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.